What's new? Log in Free sign up

Filing search / Olema Pharmaceuticals, Inc. / "Access"

Search information

Olema Pharmaceuticals, Inc.

Companies

"Access"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

52 results

Newest first Best match first

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

providers in our supply chain) may fail or suffer security or data privacy breaches or other unauthorized or improper access to, use of, or destruction … of geopolitical and macroeconomic events discussed above, could adversely increase our need to access capital and likewise, adversely impact our ability

6 Aug 24

4:15pm

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

with MandalMed, Inc. (the “MandalMed Services Agreement”) to have access to and use a portion of approximately 5,762 square feet of space for the use … to extend the agreement term to November 2023. As part of the sixth amendment, the Company gained access to use additional space of approximately 2,130

8 May 24

4:15pm

OLMA Olema Pharmaceuticals, Inc.

Additional proxy soliciting materials

! This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access … Easy Online Access — View your proxy materials and vote. When you go online, you can also help the environment by consenting to receive electronic

OLMA Olema Pharmaceuticals, Inc.

Definitive proxy

adopted by the Securities and Exchange Commission, or the SEC, we have elected to provide access to our proxy materials over the internet. Accordingly … Meeting, including at any adjournments or postponements of the Annual Meeting. All stockholders will have the ability to access the proxy materials

26 Apr 24

5:07pm

OLMA Olema Pharmaceuticals, Inc.

and any other product candidates we may develop; our ability to access capital resources on favorable terms, or at all; and our ability to retain … or other unauthorized or improper access to, use of, or destruction of our proprietary or confidential data, employee data, or personal data, which

11 Mar 24

4:15pm

11 Mar 24

4:15pm

Prospectus supplement

Shelf registration

31 Jan 24

4:21pm

Entry into a Material Definitive Agreement

Prospectus supplement for primary offering

opi qppr3rud368ms

Quarterly report

7 Nov 23

4:12pm

h5ugi67rkjx273s

Olema Oncology Announces Combined Financing for Up to $180 Million

Quarterly report

8 Aug 23

4:12pm

Quarterly report

9 May 23

4:08pm

Quarterly report

9 May 23

4:08pm

8p1lhgc5bjgaae 8gp

Additional proxy soliciting materials

Definitive proxy

28 Apr 23

4:05pm

Amendments to Articles of Incorporation or Bylaws

Quarterly report

8 Nov 22

4:45pm

yae5nar970axobn

Quarterly report

9 Aug 22

12:00am

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.